Apr 20, 2020
Strategic Review Update including Formal Sale Process Appointment of Noble Capital Markets, Inc.
Mar 31, 2020
Announcement of Strategic Review, Termination of R&D Programme, Update on EU GlioKIDS Grant, Directorate Changes
Jan 8, 2020
Positive Results from MTD201-102 Study Support Subcutaneous Route for Long-Acting Octreotide Product
Dec 5, 2019
Midatech Pharma announces confirmation of a €2.6 million EU Grant for further clinical development of MTX110 for the treatment of Diffuse Intrinsic Pontine Glioma, a rare and fatal form of childhood brain cancer
Midatech Science
Read More
Read More